stella
beta
Novel Soluble Epoxide Hydrolase Inhibitor for Neuropathic Pain in Patients With Spinal Cord Injury — Stella
Recruiting
Back to Spinal Cord Injuries trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
AU Medical Center, Augusta, Georgia
View full record on ClinicalTrials.gov